Innate Pharma S.A. (EPA:IPH)
1.560
+0.014 (0.91%)
Jun 27, 2025, 5:35 PM CET
Innate Pharma Employees
Innate Pharma had 181 employees as of December 31, 2024. The number of employees increased by 2 or 1.12% compared to the previous year.
Employees
181
Change (1Y)
2
Growth (1Y)
1.12%
Revenue / Employee
€111,166
Profits / Employee
€273,320
Market Cap
153.35M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
EssilorLuxottica Société anonyme | 153,498 |
Sanofi | 82,878 |
Sartorius Stedim Biotech | 9,901 |
bioMérieux | 14,754 |
Eurofins Scientific SE | 62,696 |
Ipsen | 5,358 |
Virbac | 6,365 |
emeis Société anonyme | 83,494 |
Innate Pharma News
- 11 days ago - Innate Pharma Announces Its Participation in H.C. Wainwright and Wolfe Research Healthcare Conferences - Business Wire
- 15 days ago - Innate Pharma Highlights Preclinical Antitumor Activity of IPH6501 in Diffuse Large B-Cell Lymphoma and Follicular Lymphoma at the 2025 European Hematology Association (EHA) Congress - Business Wire
- 4 weeks ago - Innate Pharma Announces Its Participation in Jefferies and Goldman Sachs Healthcare Conferences - Business Wire
- 5 weeks ago - Innate Pharma Highlights Durable Responses to Lacutamab in Sezary Syndrome and Mycosis Fungoides - Business Wire
- 5 weeks ago - Outcome of Innate Pharma's 2025 Annual General Meeting - Business Wire
- 5 weeks ago - Innate Pharma Highlights Abstracts Selected for ASCO 2025 Annual Meeting - Business Wire
- 6 weeks ago - Innate Pharma Highlights ANKET® Abstracts Selected for the EHA 2025 Congress - Business Wire
- 6 weeks ago - Innate Pharma S.A. (IPHA) Q1 2025 Earnings Call Transcript - Seeking Alpha